SCHEMBL4352637

SCHEMBL4352637

[SiH4].c1ccc(-c2ccccc2-c2ccccc2-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
HSD17B10 Q99714 2/20 0.55
MAPK1 P28482 2/20 0.55
HPGD P15428 1/20 0.55
BCL2L1 Q07817 1/20 0.55
CYP2A6 P11509 1/20 0.55
BACE1 P56817 1/20 0.50
PTGS2 P35354 1/20 0.48
DPP4 P27487 1/20 0.48
HDAC4 P56524 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
GPR55 Q9Y2T6 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
BCAT2 O15382 1/20 0.44
NISCH Q9Y2I1 1/20 0.43
DCUN1D1 Q96GG9 1/20 0.43
MEN1 O00255 2/20 0.42
APAF1 O14727 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414275 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL29352295 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL29414264 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL192419 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL31265362 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL27816522 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL30332559 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL608537 0.96 ALDH1A1 (0.58) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL29355309 0.93 ALDH1A1 (0.55) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL21447 0.93 ALDH1A1 (0.61) ALDH1A1HSD17B10MAPK1HPGDBCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054649-A1 Bridged Organosilane and Production Method Thereof KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-02-26 US claimed
US-20090054649-A1 Bridged Organosilane and Production Method Thereof KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054649-A1 Bridged Organosilane and Production Method Thereof C5, CCNE1, QSOX1 ALDH1A1 866/4885HSD17B10 4059/4885MAPK1 3078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.